Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
about
The promise of neuroprotective agents in Parkinson's diseaseProteome analysis of human substantia nigra in Parkinson's diseaseBiomarkers of manganese intoxicationOxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometryThe role of oxidative stress in Parkinson's diseaseGlutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processesN-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunitiesAutophagy, mitochondria and oxidative stress: cross-talk and redox signallingNeuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent PerspectivesThe Role of Oxidative Stress in Neurodegenerative DiseasesNeuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathwaysBacopa monnieri as an Antioxidant Therapy to Reduce Oxidative Stress in the Aging BrainOxidative Stress in Neurodegenerative DiseasesThe role of lipid peroxidation in neurological disordersRelevance of the glutathione system in temporal lobe epilepsy: evidence in human and experimental modelsMechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylationThe role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelismMitochondrial glutathione: features, regulation and role in diseaseThe antioxidative effect of electro-acupuncture in a mouse model of Parkinson's diseaseSerotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson's DiseaseWhat is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?Parkinson's disease as a result of agingAstrocytes protect against diazinon- and diazoxon-induced inhibition of neurite outgrowth by regulating neuronal glutathioneProtective effect of nuclear factor E2-related factor 2 on inflammatory cytokine response to brominated diphenyl ether-47 in the HTR-8/SVneo human first trimester extravillous trophoblast cell lineDopamine and paraquat enhance α-synuclein-induced alterations in membrane conductanceBiology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorderAge-related changes in glutathione and glutathione-related enzymes in rat brain1-Methyl-4-phenyl-pyridinium time-dependently alters expressions of oxoguanine glycosylase 1 and xeroderma pigmentosum group F protein in PC12 cellsFree radicals and hearing. Cause, consequence, and criteriaS-glutathionylation: from molecular mechanisms to health outcomesGlutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neuronsPomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease.Protective effect of tetrahydroxystilbene glucoside on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway.Rapid purification and mass spectrometric characterization of mitochondrial NADH dehydrogenase (Complex I) from rodent brain and a dopaminergic neuronal cell line.Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function.Antiapoptotic role of NF-kappaB in the auto-oxidized dopamine-induced apoptosis of PC12 cells.The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induces apoptosis in mouse nigrostriatal glia. Relevance to nigral neuronal death and striatal neurochemical changes.Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells.Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells.Oxidative inactivation of mitochondrial aconitase results in iron and H2O2-mediated neurotoxicity in rat primary mesencephalic cultures.
P2860
Q21129436-29980F4A-3913-40B8-9B44-9E1EA5A44004Q21245637-1DF23989-64C0-424D-8B65-DBDBDDB7D426Q23923587-235E6AF5-6CBA-40FA-B2B2-AD4CB5F5FCD6Q24307861-E8090F5F-CB5E-4C90-A553-5B21C037511FQ24307946-0604BD3F-1567-44D6-B575-6944939A9919Q24530150-C7D135DC-2FF2-4F23-8F25-346BEDB138B8Q24568289-4339F982-FF42-44C5-8A0C-39B25B6E0B21Q24608960-21B82C4C-F7D2-499E-A564-530F22CC32FDQ26747508-7BCAF308-E013-4C50-93FC-C3FAAC877B99Q26771758-593ABD48-05A9-488D-B9DE-CE6E00AD8A2AQ26779424-CDAD9DEA-B5F7-4D63-8180-8376546677ADQ26786011-966AF4C8-44F2-46C7-9692-2D46CAB82B94Q26801239-22A49BAE-7821-44CE-8D85-85EB1881E909Q26829767-F90F8AB7-467A-4933-82BC-4EF7AE8CC54CQ26830615-08B3387A-A259-41BC-8784-112FE3647896Q26830954-2A7745D4-F9C0-4973-A1AF-FAB922E65A2DQ26852148-7E403225-2F89-4BD2-9E04-B4DE25889E56Q27026521-A6DB1E13-50E8-4E1B-AFEF-CA78C2758A17Q27342258-DAC14F96-B27B-473A-99C0-D87C17C4D0C6Q28079379-294F4A96-189D-410F-9665-69073C69244DQ28083203-6B8CE98B-EE4E-4AC1-A37B-49A97C74381EQ28084395-FE4CCCED-5FD0-4E4C-8CB3-D2AF2FFF83CBQ28384691-D2C7D58B-0FD5-43CB-9461-89DCD476F2C7Q28391645-7839BCC7-BFFD-4AC3-8E3D-B13F6B8D6709Q28392011-FD2252A3-0CA6-4A64-B277-4C1BEE29105EQ28392275-C19D989E-3852-428D-B874-94AA226D021CQ28576526-F8E4908B-6B5F-4F6D-ABFA-EB066DC58354Q28582595-15A7FEE8-8EF6-4004-8F31-ABA66EA14B5FQ28645793-5F5AB206-3EE3-4323-93F7-C119CBE073C3Q30398587-B1478410-4713-44EE-8CC0-667C6DB09781Q30498761-27E0FC3F-DD93-42B4-8ACB-2F1C9B95A30EQ30573637-09B7BE21-17A9-4EE0-AB1A-B7595D6F6BBAQ31038097-3EB71057-E65C-420D-AE5C-809EBC7616CCQ31135400-72E05B81-4CB7-4083-95BD-4E27B1B58D13Q31900371-8D3F9F85-A200-455D-B248-E4E35862AEC1Q32035098-06F901A1-899D-41E8-BE81-D3A3CEC53410Q33183865-FB460B76-E643-49CE-93CE-DD1B5ABE490AQ33337387-E1B37A69-C7ED-413F-8561-F98400888006Q33415997-50C1565F-328D-4CDA-BB90-2112E93BBBD6Q33504558-13010F98-4EA7-4216-B9A9-7A90A06EDD1D
P2860
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Alterations in glutathione lev ...... rders affecting basal ganglia.
@ast
Alterations in glutathione lev ...... rders affecting basal ganglia.
@en
type
label
Alterations in glutathione lev ...... rders affecting basal ganglia.
@ast
Alterations in glutathione lev ...... rders affecting basal ganglia.
@en
prefLabel
Alterations in glutathione lev ...... rders affecting basal ganglia.
@ast
Alterations in glutathione lev ...... rders affecting basal ganglia.
@en
P2093
P50
P356
P1433
P1476
Alterations in glutathione lev ...... rders affecting basal ganglia.
@en
P2093
P304
P356
10.1002/ANA.410360305
P577
1994-09-01T00:00:00Z